Publications
Detailed Information
How Second-Line Injectable Drugs Work Reply
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Cegielski, J. Peter | - |
| dc.contributor.author | Udwadia, Zarir F. | - |
| dc.contributor.author | Viiklepp, Piret | - |
| dc.contributor.author | Yim, Jae-Joon | - |
| dc.contributor.author | Menzies, Dick | - |
| dc.date.accessioned | 2024-08-08T01:23:55Z | - |
| dc.date.available | 2024-08-08T01:23:55Z | - |
| dc.date.created | 2022-07-13 | - |
| dc.date.created | 2022-07-13 | - |
| dc.date.issued | 2021-06 | - |
| dc.identifier.citation | Clinical Infectious Diseases, Vol.72 No.12, pp.E1168-E1169 | - |
| dc.identifier.issn | 1058-4838 | - |
| dc.identifier.uri | https://hdl.handle.net/10371/205702 | - |
| dc.language | 영어 | - |
| dc.publisher | University of Chicago Press | - |
| dc.title | How Second-Line Injectable Drugs Work Reply | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1093/cid/ciaa1875 | - |
| dc.citation.journaltitle | Clinical Infectious Diseases | - |
| dc.identifier.wosid | 000670819400046 | - |
| dc.identifier.scopusid | 2-s2.0-85108386581 | - |
| dc.citation.endpage | E1169 | - |
| dc.citation.number | 12 | - |
| dc.citation.startpage | E1168 | - |
| dc.citation.volume | 72 | - |
| dc.description.isOpenAccess | Y | - |
| dc.contributor.affiliatedAuthor | Yim, Jae-Joon | - |
| dc.type.docType | Letter | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordPlus | MULTIDRUG-RESISTANT TUBERCULOSIS | - |
| dc.subject.keywordPlus | OUTCOMES | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.